Nicotinic antagonist

Revision as of 18:16, 27 September 2011 by WikiBot (talk | contribs) (Protected "Nicotinic antagonist": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.


Overview

A nicotinic antagonist is a type of anticholinergic which inhibits the action at nicotinic acetylcholine receptors. These compounds are mainly used for peripheral muscle paralysis in surgery, but some centrally acting compounds such as mecamylamine and 18-methoxycoronaridine block nicotinic acetylcholine receptors in the brain and can be used for treating drug addiction.

Comparison
Mechanism Antagonist Preferred receptor Clinical use
Ganglionic blocking agents Hexamethonium Ganglion type none[1]
Mecamylamine Ganglion type
Trimethaphan Ganglion type Rarely used for blood pressure decrease during surgery[1]
Nondepolarizing neuromuscular blocking agents Atracurium Muscle type muscle relaxant in anaesthesia[1]
Doxacurium Muscle type
Mivacurium Muscle type
Pancuronium Muscle type muscle relaxant in anaesthesia[1]
Tubocurarine Muscle type Rarely used [1]
Vecuronium Muscle type muscle relaxant in anaesthesia[1]
Depolarizing neuromuscular blocking agents Succinylcholine Muscle type
Centrally acting nicotinic antagonists 18-Methoxycoronaridine α3β4

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 149

External links


Template:Receptor agonists and antagonists

Template:WikiDoc Sources